Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the fondazione italiana linfomi

Stefano Luminari, Sara Galimberti, Annibale Versari, I. Biasoli, Antonella Anastasia, Chiara Rusconi, Angela Ferrari, Mario Petrini, Martina Manni, Massimo Federico

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)e66-e68
JournalHaematologica
Volume101
Issue number2
DOIs
Publication statusPublished - Feb 1 2016

Keywords

  • FDG-PET
  • Follicular lymphoma
  • Minimal residual disease
  • Nuclear medicine
  • Progression-free survival

ASJC Scopus subject areas

  • Hematology

Cite this